好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Seizure Comorbidity Increases Odds Of 30-Day Readmission After an Index Hospitalization for Sepsis
Epilepsy/Clinical Neurophysiology (EEG)
P3 - Poster Session 3 (5:30 PM-6:30 PM)
6-032
To evaluate the independent relationship of seizures to hospital readmission within 30 days following discharge from an index hospitalization for sepsis.

Sepsis is among the most common and costly conditions associated with readmission to the hospital within 30 days post-discharge. Survivors are at a high risk for mortality and morbidity including seizures and permanent cognitive impairment. Since sepsis is associated with an increased risk for seizures, and patients with seizures have high rates of hospitalizations, we hypothesized that patients with a primary diagnosis of sepsis who also had seizures are at an increased risk for early readmission.

We analyzed data from 445,489 adult discharges derived from the National Inpatient Sample, the largest and nationally representative database of hospitalized patients, to evaluate the impact of seizure on the 30-day readmission rates among patients who are discharged with a primary diagnosis of sepsis.

Nearly one out of 15 patients discharged with a primary diagnosis of sepsis had comorbid seizures. Seizures independently increased odds of 30-day readmission by 30% among adult patients with sepsis. Additional factors associated with a significantly higher risk for hospital readmission included male sex, age 45-84 years, increased length and cost of primary admission, greater medical comorbidities, and discharge destination.

Seizures are frequent, and confer greater risk for hospital readmission within 30 days of an index hospitalization for sepsis. Increased coordination and collaboration between medicine-hospitalists and neurohospitalists may enhance the timely and appropriate management of these patients to improve their outcomes.
Authors/Disclosures
Jonah Fox, MD (Vanderbilt University Medical Center)
PRESENTER
No disclosure on file
Alain Z. Lekoubou Looti, MD (Penn StateHealth, Hershey Medical Center) Dr. Lekoubou Looti has nothing to disclose.
No disclosure on file
Bruce I. Ovbiagele, MD, MSc, FAAN (San Francisco VA) Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities.